Abbott To Try For Summary Judgment In TriCor Suit
By Richard Vanderford ( August 5, 2009, 5:43 PM EDT) -- Defendant drug companies Abbott Laboratories and Fournier Industrie et Sante have said they will move for summary judgment in a suit lodged by more than a dozen states alleging the companies conspired to block the release of a generic version of cholesterol drug TriCor with meritless patent infringement suits....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.